Erudio Healtherudio.com
Sponsor
Sichuan Kelun-Biotech Biopharmaceutical trials: what clinicians said in public
HCP commentary reports on 3 clinical trials sponsored by Sichuan Kelun-Biotech Biopharmaceutical: OptiTROP-Lung04, OptiTROP-Lung06 and SKB264-Ⅱ-08. Each covers what clinicians said in public about one trial, on podcasts, videos and posts, every statement linked to its source. Below them, 7 more trials with public commentary and no report yet.
Listed by lead sponsor as registered on ClinicalTrials.gov (Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.). A trial led by a partner or a research group is on that sponsor's page. Only trials with public clinician commentary found are listed, not every trial the sponsor runs.
| Trial | Indication | Phase | Statements | Sources | Size | Checked | Preview |
|---|---|---|---|---|---|---|---|
| OptiTROP-Lung04 NCT05870319 · Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | EGFR-TKI-resistant, EGFR-mutated advanced NSCLC | Phase 3 | 125 | 36 | Focused | Nov 20, 2026 | Preview |
| SKB264-Ⅱ-08 NCT05631262 · Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | advanced solid tumors | Phase 2 | 62 | 8 | Focused | Nov 19, 2026 | Preview |
| OptiTROP-Lung06 NCT06711900 · Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | first-line PD-L1-negative advanced non-squamous non-small cell lung cancer | Phase 3 | 13 | 8 | Focused | Oct 29, 2026 | Preview |
| No report yetTrials with public commentary we haven't built a report for. Size is an estimate of the verified statements the commentary we've indexed so far will yield; final coverage is set when we build the report, within 24 hours of your confirmed order. You never pay more than quoted: a report delivered at a smaller size costs that size's price. Some can also be requested as a free preview. | |||||||
| OptiTROP-Lung05 NCT06448312 · Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. DeepView → | first-line PD-L1-positive advanced non-small cell lung cancer | Phase 3 | Deep | View | |||
| OptiTROP-Breast01 NCT05347134 · Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. DeepView → | Not given | Phase 3 | Deep | View | |||
| OptiTROP-Lung01 NCT05351788 · Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. DeepView → | advanced or metastatic non-small cell lung cancer | Phase 2 | Deep | View | |||
| NCT05445908 NCT05445908 · Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. FocusedView → | Not given | Phase 2 | Focused | View | |||
| NCT05265091 NCT05265091 · Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. FocusedView → | RET fusion/mutant advanced solid tumors | Phase 1/Phase 2 | Focused | View | |||
| NCT06670196 NCT06670196 · Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. FocusedView → | first-line EGFR-mutated locally advanced or metastatic non-squamous NSCLC | Phase 3 | Focused | View | |||
| NCT06736327 NCT06736327 · Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. FocusedView → | advanced solid tumors | Phase 1 | Focused | View | |||